First Citizens Bank Shares Rise 1.21% on $0.22 Billion Volume Ranking 481st as Strategic Healthcare Financing Partnership Drives Outpatient Care Growth

On September 4, 2025, First Citizens Bank (FCNCA) rose 1.21% with a trading volume of $0.22 billion, ranking 481st in market activity. The stock’s performance coincided with a strategic partnership announcement in the healthcare financing sector.

Distalmotion, a MedTech innovator, and First Citizens Bank’s Healthcare Equipment Finance division launched a new program to offer lending and leasing solutions for Distalmotion’s robotic surgery technology. The initiative targets outpatient healthcare providers seeking flexible financing for advanced medical equipment. First Citizens highlighted its expertise in healthcare banking and experience supporting medical device firms, emphasizing its role in fostering growth for cutting-edge technologies like the DEXTER® Robotic Surgery System.

Joseph Turner, leading strategic market development at First Citizens, noted the collaboration aligns with the bank’s focus on innovation and customer-centric financial solutions. Todd Beaver, head of the healthcare equipment finance group, emphasized the bank’s commitment to leveraging its sector knowledge to support technological advancements in outpatient care, a growing segment in the healthcare industry.

Backtest data from Yahoo Finance shows FCNCA’s 52-week range of $19.30–$24.42 and a trailing P/E ratio of 0.38. Over the past year, the stock returned 3.66% compared to the S&P 500’s 17.79%. Its 5-year return of -17.49% underperformed the S&P 500’s 89.73% growth, reflecting broader market dynamics.